研究チーム - Stabilis 4.0

最新更新 :
19/11/2024

研究チーム - University of Southern california, School of Pharmacy

PDF

アメリカ

University of Southern california, School of Pharmacy

Los Angeles

E-メール

引用文献

引用文献

(20)

1

Extended stability of ascorbic acid in 5% dextrose injection and 0.9% sodium chloride injection.
Chin A, Liu S, Ting-Chan J, Gill MA. ()
Am J Health-Syst Pharm - 2005 - ; 62: 1073-1074.

2

Stability and antibacterial activity of cefepime during continuous infusion.
Sprauten PF, Beringer PM, Louie ST, Synold TW, Gill MA. ( beringer@usc.edu)
Antimicrob Agents Chemother - 2003 - ; 47: 1991-1994.

3

Stability of irinotecan hydrochloride in aqueous solutions.
Li WY, Koda RT. (mppugari@hsc.usc.edu)
Am J Health-Syst Pharm - 2002 - ; 59: 539-544.

4

Activity of dalteparin sodium in polypropylene syringes.
Louie S, Chin A, Gill MA. (mgill@hsc.usc.edu)
Am J Health-Syst Pharm - 2000 - ; 57: 760-762.

5

Stability of sumatriptan succinate in polypropylene syringes.
Nii LJ, Chin A, Cao TM, Gill MA. ()
Am J Health-Syst Pharm - 1999 - ; 56: 983-985.

6

Five-day stability of vinorelbine in 5% dextrose injection and in 0.9% sodium chloride injection at room temperature.
Lieu CL, Chin A, Gill MA. ()
Int J Pharm Compound - 1999 - ; 3: 67-68.

7

Stability of milrinone lactate 200 microg /mL in 5% dextrose injection and 0.9% sodium chloride injection.
Wong F, Gill MA. ()
Int J Pharm Compound - 1998 - ; 2: 168-169.

8

Stability of milrinone lactate in 5% dextrose injection and 0.9% sodium chloride injection at concentrations of 400, 600 and 800 microg/mL.
Nguyen D, Gill MA, Wong F. ()
Int J Pharm Compound - 1998 - ; 2: 246-248.

9

Stability of granisetron hydrochloride with dexamethasone sodium phosphate for 14 days.
Chin A, Moon YSK, Chung KC, Gill MA. ()
Am J Health-Syst Pharm - 1996 - ; 53: 1174-1176.

10

Compatibility of ondansetron hydrochloride and piperacillin sodium-tazobactam sodium during simulated Y-site administration.
Chung KC, Moon YSK, Chin A, Ulrich WU, Gill MA. ()
Am J Health-Syst Pharm - 1995 - ; 52: 1554-1556.

11

Stability of granisetron hydrochloride in a disposable elastomeric infusion device.
Chung KC, Chin A, Gill MA. ()
Am J Health-Syst Pharm - 1995 - ; 52: 1541-1543.

12

Stability of piperacillin sodium-tazobactam sodium in polypropylene syringes and polyvinyl chloride minibags.
Moon YSK, Chung KC, Chin A, Gill MA. ()
Am J Health-Syst Pharm - 1995 - ; 52: 999-1001.

13

Stability of piperacillin sodium-tazobactam sodium in peritoneal dialysis solutions
Park TW, Le-Bui LP, Chung KC, Rho JP, Gill MA. ()
Am J Health-Syst Pharm - 1995 - ; 52: 2022 - 2024.

14

Stability of ranitidine hydrochloride with ondansetron hydrochloride or fluconazole during simulated Y-site administration.
Pompilio FM, Fox JL, Inagaki K, Burm JP, Jhee S, Gill MA. ()
Am J Hosp Pharm - 1994 - ; 51: 391-394.

15

Stability of paclitaxel and fluconazole during simulated Y-site administration.
Burm JP, Choi JS, Jhee SS, Chin A, Ulrich RW, Gill MA. ()
Am J Hosp Pharm - 1994 - ; 51: 2704-2706.

16

Stability of paclitaxel with ondansetron or ranitidine hydrochloride during simulated Y site administration.
Burm JP, Jhee SS, Chin A, Moon YSK. ()
Am J Hosp Pharm - 1994 - ; 51: 1201-1204.

17

Stability of piperacillin sodium-tazobactam sodium and ranitidine hydrochloride in 0.9% sodium chloride injection during simulated Y-site administration.
Choi JS, Burm JP, Jhee SS, Chin A, Ulrich RW, Gill MA. ()
Am J Hosp Pharm - 1994 - ; 51: 2273-2276.

18

Stability of ondansetron hydrochloride stored in a disposable, elastomeric infusion device at 4°C.
Jhee SS, Jeong EW, Chin A, Inagaki K, Fox JL, Gill MA. ()
Am J Hosp Pharm - 1993 - ; 50: 1918-1920.

19

Visual compatibility of ciprofloxacin with selected components of total parenteral nutrient solutions during simulated Y-site injection.
Percy LA, Rho JP. ()
Am J Hosp Pharm - 1993 - ; 50: 715-716.

20

Chemical compatibility of cefmetazole sodium with ranitidine hydrochloride during simulated Y-site administration.
Inagaki K, Gill MA, Okamoto MP, Takagi J. ()
J Parenter Sci Technol - 1993 - ; 47: 35-39.

薬剤一覧

研究分子

(21)

Mentions Légales